News headlines about LHC Group (NASDAQ:LHCG) have trended somewhat positive this week, according to Accern. The research group identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. LHC Group earned a news sentiment score of 0.25 on Accern’s scale. Accern also assigned news headlines about the health services provider an impact score of 46.8076247885673 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
These are some of the news headlines that may have effected Accern’s scoring:
- Comerica Bank Grows Stake in LHC Group, Inc. (LHCG) (americanbankingnews.com)
- LHC Group and Almost Family Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger (finance.yahoo.com)
- LHC Group (LHCG) Set to Announce Quarterly Earnings on Wednesday (americanbankingnews.com)
- LHC Group, Inc. (LHCG) Receives Average Recommendation of “Buy” from Analysts (americanbankingnews.com)
LHCG has been the subject of a number of research reports. ValuEngine lowered shares of LHC Group from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Royal Bank of Canada raised their price target on shares of LHC Group from $70.00 to $81.00 and gave the company an “outperform” rating in a report on Tuesday, November 7th. SunTrust Banks reissued a “buy” rating and issued a $75.00 price target on shares of LHC Group in a report on Friday, November 3rd. Zacks Investment Research lowered shares of LHC Group from a “buy” rating to a “hold” rating in a report on Friday, November 10th. Finally, Oppenheimer raised their price target on shares of LHC Group from $68.00 to $80.00 and gave the company an “outperform” rating in a report on Tuesday, November 7th. One analyst has rated the stock with a sell rating, three have given a hold rating and nine have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $77.10.
Shares of LHC Group (NASDAQ:LHCG) opened at $64.27 on Friday. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. The firm has a market cap of $1,175.18, a P/E ratio of 27.70, a P/E/G ratio of 1.66 and a beta of 0.71. LHC Group has a fifty-two week low of $47.29 and a fifty-two week high of $76.14.
TRADEMARK VIOLATION WARNING: This piece was reported by Transcript Daily and is the property of of Transcript Daily. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://transcriptdaily.com/2018/02/25/lhc-group-lhcg-receives-daily-media-sentiment-rating-of-0-25.html.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.